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Conjugated linoleic acid (CLA) has been shown to reduce body fat mass in various experimental animals. It is valuable to identify its influence on enzymes
involved in energy expenditure, apoptosis, fatty acid oxidation and lipolysis. We investigated isomer-specific effects of high dose, long treatment of CLA (75.4
μmol/L, 8 days) on protein and gene expression of these enzymes in cultured 3T3-L1 cells. Proteomics identified significant up- or down-regulation of 52
proteins by either CLA isomer. Protein and gene expression of uncoupling protein (UCP) 1, UCP3, perilipin and peroxisome proliferator-activated receptor (PPAR)
α increased whereas UCP2 reduced for both CLA isomers. And eight-day treatment of trans-10,cis-12 CLA, but not cis-9,trans-11 CLA, significantly up-regulated
protein and mRNA levels of PKA (Pb.05), CPT-1 and TNF-α (Pb.01). Compared to protein expression, both isomers did not significantly influence the mRNA
expression of HSL, ATGL, ACO and leptin. In conclusion, high-dose, long treatment of cis-9,trans-11 CLA did not promote apoptosis, fatty acid oxidation and
lipolysis in adipocytes, but may induce an increase in energy expenditure. trans-10,cis-12 CLA exhibited greater influence on lipid metabolism, stimulated
adipocyte energy expenditure, apoptosis and fatty acid oxidation, but its effect on lipolysis was not obvious.
© 2010 Elsevier Inc. All rights reserved.Keywords: Conjugated linoleic acid; 3T3-L1; Lipid metabolism1. Introduction
Conjugated linoleic acid (CLA) [1] refers to a mixture of
positional and geometric isomers of conjugated octadecadienoic
acids. CLA is effective [2]as anticarcinogenic, antidiabetic and
antilipogenic agents in animal models [3,4]. CLA used in most
feeding studies usually contained two major isomers: cis-9,trans-
11 and trans-10,cis-12 CLA, while concentrations of other isomers
are much lesser. Dietary supplementation of CLA has been shown
to reduce body fat mass in various experimental animal experi-
ments [5–8] and human subjects [1,9], However, a recent study
showed that CLA supplementation had no significant effect on
body composition or energy expenditure in adult women, which
contrasts with previous findings [10]. In addition cis-9,trans-11
CLA has different effects on lipid metabolism compared to trans-
10,cis-12 CLA. Comparative studies investigating the effects of
these two isomers found out that trans-10,cis-12 CLA is effective in⁎ Corresponding author.
E-mail addresses: daphniezhai@hotmail.com (D.-P. Yang),
daphnie1983@163.com (J.-Q. Chen).
0955-2863/$ - see front matter © 2010 Elsevier Inc. All rights reserved.
doi:10.1016/j.jnutbio.2009.09.007reducing lipid accumulation of adipocytes, but not cis-9,trans-11
CLA [11–13].
The mechanisms of the CLA's lipid-lowering effects s are
considered to be related to modulate the expressions of protein and
gene relevant to energy expenditure, apoptosis, fatty acid oxidation,
lipolysis, differentiation and lipogenesis [6]. peroxisome proliferator-
activated receptor (PPAR) γ is highly expressed in fat tissues and it
has been shown to stimulate lipogenesis and adipose differentiation
[14]. Reduced PPARγ plays a role in down-regulating the lipogenic
enzymes, thus leading to reduced lipid accumulation. Several studies
have demonstrated that chronic treatment of trans-10,cis-12 CLA
decreases mRNA expression of PPARγ [13,15,16], thus the antilipo-
genic effect of CLA was not investigated in this study.
Most studies on specific effects of CLA isomers have been
conducted in cultured 3T3-L1 cells. He et al. [17] concluded that the
effects of CLA on fatty acid accumulation of 3T3-L1 cells is dependent
on the isomer type, treatment period, and dose. However, present in
vitro studies are usually conducted in short treatment period and low
dose [18,19]. The purpose of this study was to examine the effect of
high-dose, long treatment period of two major CLA isomers on the
expression of genes relevant to energy expenditure, apoptosis, fatty
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regulated by either the cis-9,trans-11 isomer of CLA or the trans-10,
cis-12 of CLA were identified by proteomics in the present study.
2. Materials and methods
2.1. Chemicals and reagents
All reagents were purchased from Sigma (St. Louis, MO, USA) and Merck (São
Paulo, SP, Brazil). MilliQ water (Millipore, Bedford, MA, USA) was used for all solutions.
2.2. Experimental design and cell culture
The 3T3-L1 preadipocytes were cultured as described by Frost and Lane [20].
Briefly, the cells were grown in Dulbecco's modified Eagle's medium containing 10%
fetal bovine serum in a humidified 5% CO2 atmosphere at 37°C for proliferation until
confluence was attained. To induce differentiation, all the media including the control
and the CLA treatments were supplemented with 0.1 μmol/L dexamethasone, 1 mmol/
L methyl-isobutylxanthine, and 0.1 μmol/L insulin at 2 days postconfluence. The time
of addition of differentiation medium was designated as 0 day. Stock solutions of 21.1
mg CLA per milliliter of dimethyl sulfoxide (DMSO) were diluted to obtain final
concentration 75.4 μmol/L (21.1 mg/L) in culture medium. The final concentration of
DMSO in culture medium was 0.1%. Cultures were continuously (from Day 2 to Day 8)
treated with 75.4 μM of cis-9,trans-11 CLA or trans-10,cis-12 CLA in differentiation
medium. The effects of two CLA isomers were compared with the vehicle control
(DMSO only). Each treatment was replicated 6 times.
2.3. Sample solubilization and protein concentration determination
3T3-L1 cells were collected by centrifugation at 1400×g for 5 min at 4°C, and
washed twice with phosphate-buffered saline (PBS) (0.01 M phosphate 0.145 M
NaCl), pH 7.2. Then, they were lysed by 10 cycles of freezing and thawing in
hypotonic PBS buffer (13.6 mM NaCl, 0.27 mM KCl, 0.4 mM Na2HPO4, 0.15 mM
KH2PO4) containing a cocktail of protease inhibitors (Protease Arrest Geno
Technology) [21,22]. The lysate was centrifuged at 14,000×g for 15 min at 4°C to
remove insoluble material and the soluble proteins in the resulting supernatant were
precipitated with 10% (v/v) TCA and washed with cold acetone under the same
conditions. Finally, the pellet was resuspended in isoelectrical focusing (IEF) buffer
[9 M urea, 4% 3-[(3-cholamidopropyl)-dimethylamminio]-1-propane sulfonate
(CHAPS), 40 mM dithiothreitol (DTT) and 2% Pharmalyte 3–10]. Resuspension was
allowed to proceed for 1 h at room temperature. Protein concentration was
determined using the 2D Quant Kit (GE Healthcare). Extracts were stored as single-
use samples of 500 μg at −80°C until analysis.
2.4. Two-dimensional electrophoresis
Electrophoresis conditions were used in the experiments as previously described
[22]. Briefly, 500 μg of protein was diluted to a final volume of 350 μL in rehydration
solution (9 M urea, 2% CHAPS, 40 mM DTT, 0.5% immobilized pH gradient [IPG] buffer
pH 3–10, trace bromophenol blue) and applied to the IPGstrip (18 cm, pH 3–10
nonlinear; Amersham Biosciences) by in-gel rehydration. All isoelectric focusing took
place on an IPGphor system (Amersham Biosciences) using parameters described
previously [22].After reduction and alkylation in the equilibration buffer [6 M urea, 2%
sodium dodecyl sulfate (SDS), 300 mM Tris–HCl buffer pH 8.8, 20% Glycerol], IPG strips
(18 cm, pH3–10 nonlinear; Amersham Biosciences) were directly transferred to the
second dimension gel. Proteins were separated on 12.5% SDS-polyacrylamide gel
electrophoresis gels using an Ettan Daltsix large vertical system (Amersham
Biosciences) and standard Tris/glycine/SDS buffer until the tracking dye left the gel.Table 1
Primers for qRT-PCR of mRNAs
Gene Forward primer (5′-3′)
β-Actin TCCATCATGAAGTGTGACGT
PPARα CCTFAAAGATTCGGAAACTGC
HSL TCGGGGAGCACTACAAACG
PKA ATGGACAGAAGATCGTGGTGC
Leptin TCCAGGATGACACCAAAACC
CPT TATCGCCACCTGCTGAACC
UCP1 GCTACACGGGGACCTACAATG
UCP2 GGTCGGAGATACCAGAGCAC
UCP3 ATGAGTTTTGCCTCCATTCG
Perilipin CATGTCCCTATCCGATGCC
ACO GCCTTTGTTGTCCCTATCCG
TNF-α TTCTCATTCCTGCTTGTGGC
ATGL GGTGCCAACATTATTGAGGTG2.5. Protein visualization and image analysis
Gels were stained with colloidal Coomassie Brilliant Blue G-250 following
procedures described elsewhere [23], and documented using an ImageScanner II
densitometer (Amersham Biosciences). Image analysis was performed using Image-
Master 2D Platinum software (Amersham Biosciences). Three independent cell
suspensions for each sample were compared. To determine experimental pI and Mr
coordinates for each single spot, 2DE gels were calibrated using a select set of reliable
identification landmarks distributed throughout the entire gel.
2.6. Protein digestion, peptide extraction and mass spectrometric analysis
Protein spots were manually excised and treated for digestion as previously
described [21,22]. Mass spectra were acquired on a 4700 Proteomics Analyzer mass
spectrometer (MALDI-TOF/TOF) operating in delayed reflector mode with an
accelerated voltage of 20 kV. MS/MS analysis was performed by precursor ion
fragmentation of the five more intense peptides in the presence of N2 as collision
induced dissociation (CID) gas at a collision cell pressure of 2.8×10−6 Torr. The
mass spectrometer was calibrated using the Sequazyme Standard kit (Applied
Biosystem).
2.7. Database search
A combined search using the MS and MS/MS data against the National Center for
Biotechnology non-redundant (NCBInr) database was performed by using the GPS
Explorer Protein Analysis Software (Applied Biosystems) and Mascot database search
engine. Mascot search parameters were: tryptic peptides with 1 missed cleavage
allowed; no taxonomic restrictions; fixed modifications: carbamidomethylation of Cys
residues; variable modifications: Met-oxidation, N-terminal acetylation; mass accuracy
within 100 ppm in MS and 0.5 Da for CID data. A global MASCOT score greater than 50
was considered significant (Pb.05). In addition, a hit was positive when a combination
of the number of matching peptides (N5) in MS mode and peptides identified by MS/
MS (N2) was found. Finally, proteins automatically identified were confirmed by
manual sequencing of at least one matching peptide. Biological processes of identified
proteins were assigned according to gene ontology annotations available at The
Institute for Genomic Research Trichomonas vaginalis genome project database
(http://www.tigr.org/tdb/e2k1/tva1/GeneNameSearch.shtml).
2.8. RNA isolation and qRT-PCR
After eight days of treatment, culture medium was removed, total RNA was
isolated by using the RNeasy kit (Qiagen, Valencia, CA, USA). DNA contamination was
eliminated by on-column DNase treatment (RNase-Free DNase Set; Qiagen). Total RNA
concentration was determined spectrophotometrically at 260 and 280 nm (Eppendorf,
Hamburg, Germany). The ratio of light absorbance at 260 nm to that at 280 nm was
between 1.8 and 2.1 for all samples. Total RNA were subjected to cDNA synthesis using
ReverTra Ace Kit (Toyobo, Osaka, Japan).
Quantitative real-time reverse transcriptase PCR (qRT-PCR) assays were
developed for genes of interest (Table 1), and each sample was analyzed with β-
actin as the internal control. Specific sense and antisense primers used to amplify
cDNA were purchased from Shanghai Shenergy Biocolor Bioscience & Technology
Company. The final PCR reaction volume of 50 μl contained 25μl SYBR Green PCR
Master Mix (real-time PCR Master Mix; Toyobo, Osaka, Japan), 1 μl cDNA template, 1
μl primer mixture and 23 μl water. Thermal cycling was carried out with a 5 min
denaturation step at 94°C, followed by 40 two-step cycles: 30 s at 94°C, 30 s at 60°C
and 30 s at 72°C. Amplification data were collected by the ABI PRISM 7900 and
analyzed by the Sequence Detection System 2.0 software (Applied Biosystems, Foster
City, CA, USA).Reverse primer (5′-3′) Accession No.
GAGCAATGATCTTGATCTTCAT M12481
GGGTTGTTGCTGGTCTTTCC NM_011144
CACGCAACTCTGGGTCTATGG U08188
GCAGCCCGAGGACGATT NM_021880
CTCAGAATGGGGTGAAGCC NM_008493
TTGAAGGTGACGAAGGTGGT AF320000
CGTCATCTGCCAGTATTTTGTT NM_009463
TGAGGTTGGCTTTCAGGAGA NM_011671
CCAGTTCCCAGGCGTATCA NM_009464
TCGGTTTTGTCGTCCAGG BC096685
TACATACGTGCCGTCAGGC NM_015729
GGCTACAGGCTTGTCACTCG NM_013693
AAACACGAGTCAGGGAGATGC AY894805
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Results are presented as least squares mean±S.E.M. Data were analyzed using
pairwise comparisons of mean values with Fisher's least significant difference test in
SAS. Values are expressed relative to the control. Differences were considered
significant at Pb.05.
3. Results
3.1. 2DE and image analysis
Representative 2DE gel images of Coomassie G-stained soluble
proteins from three cell suspensions are shown in Fig. 1. Detection of
spots and comparison of the protein expression was carried out using
the ImageMaster 2D Platinum software. About 700 spots were
detected in the blank (Fig. 1A), cis-9,trans-11 CLA treatment (Fig.
1B) and trans-10,cis-12 CLA treatment gels (Fig. 1C), corresponding to
1% of the theoretical proteome. Proteins within a molecular mass
range of approximately 10–100 kDa were detected in the pH 3–10
gels. Image analyses were performed by comparing at least three
representative gels that were obtained from three different cell
suspensions for each isolate. The 2DE protein spot profiles obtained
from these separate protein preparations were highly reproducible in
terms of both total number of protein spots and their relative
positions and intensities. Automatic comparison of matched gels
revealed differences between the protein profiles of the isolates. The
pixel volume of each spot provided the basis for comparison of
protein expression between cis-9,trans-11 CLA treatment and trans-
10,cis-12 CLA treatment. The pixel volume for each spot was
calculated based on spot intensity and spot area, followed by
normalization with the total pixel volume of all the spots revealed
in the gel image. Protein spot intensities showing a twofold increase
or decrease were considered as differentially expressed. This cut-off
was chosen based on previous observations that cis-9,trans-11 CLA
treatment overexpress at least by two-fold on some enzymes when
compared to trans-10,cis-12 CLA treatment [24]. Differential proteo-
mic analyses using a 2–3-fold cutoff have also been conducted by
others [25–27].
3.2. Identification and functional description of differentially
expressed proteins
The different expression levels of the proteins differentially
expressed between the isolates were identified by an automatic
NCBInr database search using combined MS and MS/MS data. This
approach allowed the identification of 50 proteins, of which 25
correspond to different functional genes (Table 1). All identifications
were confirmed bymanual interpretation of the tandemmass spectra.
When compared to the cis-9,trans-11 CLA treatment and control
protein profile, the trans-10,cis-12 CLA treatment presented 14 up-
regulated proteins which are Patatin-like phospholipase domain-
containing protein 2 (125%), carnitine palmitoyltransferase 1A
(150%), hormone-sensitive lipase (200%), perilipin (175%), PPARα
(200%), UCP1 (150%), UCP3 (200%), EP2E protein (125%), tumor
necrosis factor α (TNF-α) (200%), MHC class II antigen (150%), 5′-
AMP-activated protein (200%), rearranged T-cell receptor (125%),
calsequestrin-2 (125%), aspartate aminotransferase (125%) and two
down-regulated proteins which are UCP2 (50%) and Stearoyl-CoA
desaturase (75%) (Fig. 1 and Table 2).Fig. 1. Comparison of 2-DE patterns of 3T3-L1 cell lines treated with. (A) placebo; (B)
cis-9,trans-11 CLA; (C) trans-10,cis-12 CLA. Fifty-two protein spots were found to vary
in a significant way during the treatment.
Table 2
Proteins identified by MALDI-TOF MS and their expression variations in different treatment
Code Protein name Swiss-prot
accession
MW no.
theor.
PI theor.
pep.
Matching pep./
Identified by
MS/MS
Pep. sequence Protein
score
Ion
score
Expression in
cis-9,trans-11
CLA treatment
Expression in
trans-10,cis-12
CLA treatment
33 Patatin-like phospholipase
domain-containing protein 2
Q8BJ56 53657 6.02 12/3 HFSSKDELIQANVC
NIHELRVTNT
MTTLSNMLPV
397 346 ↑
9 Carnitine palmitoyltransferase
1A
P97742 88251 8.67 10/4 SYHGWMFAEHGKMSR
S ETDTIQHVKDSRH
TDVFQLGYSE
QQQVELFDFEKYPD
VRVPDGIMAAYPVTT
276 295 ↑
32 Hormone-sensitive lipase P54310 83348 6.49 17/3 VQRDTSLFLRDLR
SVSEAALAQPE
77 89 ↑
46 Perilipin Q8CGN5 55578 6.58 3/2 NPRGLLGGVVHTVQN
PAQAVSSTKGRAM
SPFSSGSPSRGLFSR
219 281 ↑ ↑
30 AMPK gamma2 Q91WG5 62997 9.71 20/4 ESSPNSNPSTSPGGIRFF
FQSPARPPLASPTYHAPLRT
PISGNALYILTHKRILKFL
DGSGTYTKLQ NTQ
189 178 ↑
52 PPARα–protein interacting
complex 320 kDa
Q8BYH8 323860 7.61 5/2 TWE LKEDVDLAKI 214 19 ↑ ↑
26 UCP2 P70406 33374 9.16 14/3 RTEGPRSLYN GL
GGGRRYQSTVEAY
KDTLLKANLMTDD
YVWRNIILMSLLHLGAL
87 90 ↓ ↓
34 Stearoyl-CoA desaturase AAR87714 41245 9.38 15/4 SAVGVTAGAHRLWS
GILLMCFILPTI
SAAHLYGYRPYDKTIS
141 145 ↓
39 UCP1 P12242 33248 7.99 17/2 TFPLDTAKVR LQI
ESL STLWKGTTPN
QFYTPKGADH SS
173 189 ↑ ↑
17 UCP3 P56501 33911 4.38 5/3 DAYRTIAREEG
FTDNFPCHFVSA
167 211 ↑ ↑
39 EP2E protein Q1RLJ2 9527 6.56 3/2 AHTAHLQETG
SVKI HFVGDIPPGI
96 78 ↑
21 Calsequestrin-2 (fragment) ACYP2 11206 9.6 4/2 VCFRMYTEDE
KNTSKGTVTGQVQ
LLSLNLVHGVF
119 134 ↑
26 Type X collagen Q9N178 65447 9.97 5/3 PRGHPGPSGP
GDMGPAGLPGPRG
SAWWQKLQIVNEY
81 90 ↑
44 TNF-α Q9QXP7 32009 5.39 13/4 EDKKACQFKRSFLKNCSG
GQPCILLKMNRIVGFRP
PESASFDLRYYPYYGKL
IQSSITFLCGKTLGT
71 68 ↑
8 Mannose-6-phosphate/
insulin-like growth factor
Q95LC9 252552 5.17 19/3 LQPLSRVGDA PYTCEGE
GVGLP EYQEEDNSTY
FDSDVGEFRAV
85 90 ↑
41 MHC class II antigen (fragment) Q5DLW7 10656 4.98 4/3 TPLGRPDADYLNGQK
KRAELDTVCK
75 69 ↑
31 5′-AMP-activated protein kinase
subunit gamma-3
Q9MYP4 56790 5.07 12/2 RDILPSDCAASASD
LTALDIFVDRRVSALPV
69 72 ↑
36 rearranged T-cell receptor
delta-chain
I46626 16950 8.93 4/2 AQKVTQDQPVVS
YFINFQKAQKSLS
66 61 ↑
20 ATP synthase e chain Q9MYT8 8232 9.71 3/2 ALFLGVAYGAKRY
RRIAAEEKKKQ
69 72 ↑
21 Phosphorylase kinase gamma
subunit
O77789 13873 9.75 5/2 CSAEEALAHPFFQQ
FENTPKAVLL
FDGEFAADVLVEF
66 61 ↑
38 Calsequestrin-2 18934 18990 4.51 9/3 YYKAFEEAAEHF
|TFDKGVAKKLSLKM
TISGTGALRIGANF
55 65 ↑
40 Aspartate aminotransferase P00506 47436 9.01 14/3 FSRDVFLPKPSWG
PRPEQWKEMATLV
53 60 ↑
18 Cyclin dependant kinase
inhibitor
Q8SPK2 16298 5.65 13/2 RALLEAGALANAPN
AWGRLPVDLAEER
IKTLNILTARKNSC
50 61 ↑
19 interleukin-4 S28187 14892 9.09 5/3 DVFAAPENTTEK
|CMKSLLSGLDRNLSSM
48 54 ↑
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Fig. 2. Effects of CLA isomers on mRNA abundance of key genes in 3T3-L1. Values are
least squares means±S.E.M., n=6. Values are expressed relative to the control. *Pb.05;
**Pb.01.
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3.3.1. Effects of trans-10,cis-12 CLA on the mRNA levels of UCP-1,UCP3,
PPARα, perilipin, CPT-1, TNF-α and PKA
The housekeeping gene β-actin was treated as an internal control.
Values are expressed relative to the vehicle control (Fig. 2). The
treatment of cis-9,trans-11 CLA led to a double increase in the
expressions of the UCP1, UCP3mRNA and PPARαmRNA (Pb.01), and a
up-regulation in the expression of perilipin mRNA by 64% (P b .05) as
compared with the control group. The mRNA level of UCP2 was
markedly inhibited by cis-9,trans-11 CLA (P b .01, dropped to 31.3%).
It is valuable to note that trans-10,cis-12 CLA showed to modulate
the genes related to lipid metabolisms in the adipocytes. Treatment of
trans-10, cis-12 CLA led a 539%, and 686%, 630% and 657% increases in
the expression of UCP-1,UCP3, PPARα and perilipin at mRNA level
respectively as compared with the control group. Meanwhile, trans-
10,cis-12 CLA markedly decreased the mRNA level of UCP2, which is
about the one fourth of the control level. Treatment of trans-10,cis-12
CLA also induced a 282% increase of CPT-1 mRNA (Pb.01), which was
much higher than those of cis-9,trans-11 CLA. Treatment of trans-10,
cis-12 CLA up-regulated the level of TNF-α mRNA by 362% (Pb.01),
treble of cis-9,trans-11 CLA treatment. Moreover, trans-10,cis-12 CLA
enhanced significantly the expression of PKA by 73.6% (Pb.05).
Compared with control, trans-10,cis-12 isomer had no effect on the
expression of HSL, ATGL, ACO and leptin.
4. Discussion
4.1. Effect of CLA isomers on energy expenditure in 3T3-L1
UCPs are mitochondrial inner-membrane transporters responsible
for heat generation through forming a pathway for proton flux fromcytosol to mitochondrial matrix [28]. They are important regulators of
thermogenesis, although the role of UCP2 and UCP3 in thermogenesis
is still controversial [29]. Metges et al. reported that cis-9,trans-11
CLA increased lipid accumulation and UCP1 mRNA expression in
primary adipocytes, whereas trans-10,cis-12 CLA increased lipolysis
and inhibited UCP1mRNA expression [18]. Wang et al. concluded that
UCP2 mRNA expression was higher by both cis-9,trans-11 CLA and
trans-10,cis-12 CLA treatments [30]. However, our results are
different from the previous studies. In the expression of UCP1,our
study results are contrasted with the in vivo effects of the mixed CLA
as previous report [7]. The up-regulation of UCP1 gene expression by
trans-10,cis-12 isomer in our study was in agreement with the study
reported by LaRosa et al. [31]. The CLA isomers increased the express
of UCP3, but reduced the mRNA levels of UCP2. The protein
expression of UCP1 and UCP3 proteins had not changed, but the
UCP2 protein was down-regulated by trans-10,cis-12 CLA treatment.
UCP1 is known to play a crucial role in increasing energy expenditure
in brown adipose tissue, the enhancement of thermogenesis is due to
up-regulation of UCP1 [32]. UCP2 is a mitochondrial inner-membrane
protein that mediates proton leakage by uncoupling adenosine
triphosphate synthesis [33] Down-regulation of UCP2 protein
expression may compromise cellular adenosine triphosphate levels
and increase metabolic efficiency and, thus increasing energy
expenditure. All in all, we conclude that both isomers increased
energy expenditure in adipocytes and trans-10,cis-12 CLA exerted a
stronger thermogenic effect than cis-9,trans-11 CLA.
4.2. Effect of CLA isomers on fatty acid oxidation in 3T3-L1
PPARα gene is predominantly expressed in tissues with high
mitochondrial and peroxisomal β-oxidation activities of fatty acids,
such as adipose tissue, liver and muscle [34]. It is a known that the
transcription factor for ACO (peroxisomal β-oxidation), CPT-1
(mitochondrial β-oxidation) and other genes involved in the cellular
fatty acid utilization pathway [2,35,36]. Increase in PPARα mediates
the up-regulation of ACO and CPT-1, thus the degree of PPARα
activation may be correlated to the degree of fatty acid β-degradation
[37]. It has been already reported that CLA act as a legend of PPARα
[24]. We found that both isomers increased mRNA and protein levels
of PPARα, though the extent was not so much in cis-9,trans-11 CLA
treatment (200% vs 630% for mRNA and 120% vs 200% for protein).
Eight days treatment of the trans-10,cis-12 CLA, but not the cis-9,
trans-11 CLA, also significantly up-regulated the gene and protein
expression of CPT-1 protein. Higher CPT-1 could be explained by the
increase in PPARα; however, the results in current study suggested
that both CLA isomers tended to inhibit ACO expression. As
mitochondrial β-oxidation is approximately twice as efficient as
peroxisomal β-oxidation [34], we still believed that fatty acid
oxidation was promoted by trans-10,cis-12 CLA in this experiment.
4.3. Effect of CLA isomers on apoptosis in 3T3-L1
Previous studies conducted by Evans et al. [21] and Hargrave et al.
[22] indicate that trans-10,cis-12 CLA is the effective isomer to promotes
apoptotic cell death in fat cells. The body fat-lowering effect of CLAmay
be partly explained by the induction of apoptosis. Tumor necrosis factor
alpha (TNF-α is a cytokine known to activate lipolysis and apoptosis in
adipocytes [23] CLA supplementation could up-regulate the level of
TNF-α [12,38].Wegot the similar results, showing the increaseof TNF-α
induced by trans-10, cis-12 CLA. The apoptotic cell death induced by
trans-10,cis-12 CLA may be associated with the enhancement of TNF-
α. As TNF-α is the mediator with both the pro- and anti-apoptotic
functions in adipocytes [23]. The increase of TNF-α expression may not
directly lead to apoptosis in the adipocytes. Other proteins involved in
apoptosis should be investigated before the conclusion can be drawn.
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of perilipin were correlated with increase in TNF-α [25], but a
paradoxical effect was observed in this study. Lepin is a lipostatic
hormone secreted by mature adipocytes. It is important in the
regulation of body weight and energy metabolism, reducing body
weight by reduced food intake and accelerated energy expenditure
[27]. It is known to up-regulate enzymes of fatty acid oxidation and
their transcription factors [39]and induce apoptosis [40]. Howev-
er, the suppression of leptin mRNA expression by trans-10,cis-12
CLA was reported by several studies [19,30,41]. We got similar
results in this experiment, though the change was not significantly
different. The reduction of leptin mRNA level was not consistent
with increase in TNF-α, because gene expression of leptin was
influenced by other factors. Reduced leptin expression indicates
the transformation of adipocytes from cells that store triglycerides
to fatty acid-oxidizing cells [39]. Therefore, we conclude that
down-regulation of leptin by trans-10,cis-12 CLA treatment is
associated with its lipid-lowering effect.
4.4. Effect of CLA isomers on lipolysis in 3T3-L1
Perilipin surrounds lipid droplets, serving as a functional barrier to
shield stored triglyceride (TG) against the basal lipolytic actions of
cellular lipases [42]. TG storage is protected by unphosphorylated
perilipin. PKA-mediated phosphorylation of HSL and perilipin
promotes perilipin movement from the surface of lipid droplets to
the cytosol, leading to increased lipolysis [43,44]. Chronic treatment
(≧48 h) of trans-10,cis-12 CLA is reported to down-regulate the
expression of perilipin [45]., but our data showed that both isomers,
especially trans-10,cis-12 CLA up-regulated the expression of perilipin
at protein andmRNA levels. This may be related to the different doses
and experimental conditions used.
Our data also showed that the levels of PKAprotein andmRNA level
was significantly enhanced by trans-10,cis-12 CLA. Up-regulation of
PKA expression is related to enhanced phosphorylation of perilipin
and HSL, thus stimulating lipolysis. For trans-10,cis-12 CLA, increase in
PKA expression attenuated the effect of increased perilipin expression.
Moreover, results from this experiment suggested that both isomers
did not present significant influence on gene expression of HSL, which
is the enzyme once known as the exclusive one to hydrolyze
triglycerides. The decline in the gene expression of HSLwas consistent
with other studies [31,45]. This change may be explained by lower
leptin level, because leptin because leptin regulates lipolysis by
controlling the level of HSL [46]. However, basal lipolysis may be
induced by other mechanisms other than the classic cAMP-driven,
PKA-mediated phosphorylation of HSL and perilipin [45]. Adipose TG
lipase (ATGL)was of interest in this study. It was recently described to
predominantly perform the initial step in TG hydrolysis [47]. But data
indicate that no significant influence in gene expression of ATGL was
obtained in either isomer treatment. Eventually, judging by the
expression of related gene and protein, we concluded that the lipolysis
effect was not affected by both trans-10,cis-12 and cis-9,trans-11 CLA.
In conclusion, after 8 days of high dose treatment, trans-10,cis-12
CLA exhibited greater influence on lipid metabolism than cis-9,trans-
11 CLA. cis-9,trans-11 CLA may induce an increase in energy
expenditure, but it had little influence on apoptosis, fatty acid
oxidation and lipolysis in adipocytes. trans-10,cis-12 CLA stimulated
adipocyte energy expenditure, apoptosis and fatty acid oxidation, but
its effect on lipolysis was not obvious.
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